Steri-Strip Application Versus Standard Wound Closure for Cesarean Section Incisions

Purpose

This study is evaluating whether Steri-Strips® provide additional benefits when used after cesarean section (C-section) surgery. Steri-Strips are adhesive strips that are commonly placed over a surgical incision to provide support while the wound heals. At our hospital, Steri-Strips are routinely used after C-sections in addition to standard wound closure techniques, although they are not considered part of the standard recommended closure method. Researchers want to determine whether adding Steri-Strips actually reduces wound complications such as infection, fluid collection under the skin, or reopening of the incision. Previous studies have shown mixed results, with some suggesting little difference in wound healing outcomes while others reported differences in scar appearance. Steri-Strips may also increase costs, add time to the surgery, and occasionally cause skin irritation or allergic reactions. Participants in this study will be randomly assigned to one of two groups. One group will receive standard cesarean wound closure with Steri-Strips, while the other group will receive standard wound closure without Steri-Strips. Researchers will compare wound healing, complications, patient outcomes, and costs between the two groups. The goal of this study is to determine whether Steri-Strips improve recovery after cesarean delivery and whether their routine use is beneficial and cost-effective. The findings may help guide future recommendations for cesarean wound care and improve outcomes for patients undergoing C-section delivery.

Conditions

  • Cesarean Section
  • Surgical Site Infection
  • Wound Dehiscence
  • Seroma

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Female patients age 18 years or older - Pregnant patients undergoing cesarean delivery at Riverside University Health System Medical Center (RUHS) - Able and willing to provide informed consent

Exclusion Criteria

  • Known allergy or hypersensitivity to Steri-Strip™ materials or adhesives - Inability or unwillingness to provide informed consent - Anticipated inability to complete the 30-day postpartum follow-up evaluation

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
Participants will be assigned using 1:1 block randomization to one of two study arms. The intervention arm will receive Steri-Strip application following standard cesarean wound closure, while the control arm will receive standard wound closure alone. Participants will remain in their assigned group throughout the study, and outcomes will be assessed within 30 days postpartum.
Primary Purpose
Prevention
Masking
None (Open Label)
Masking Description
Neither participants nor treating clinicians will be blinded to treatment allocation because Steri-Strip application is readily visible following surgery.

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Standard Closure + Steri-Strips
Participants undergo standard cesarean skin closure followed by application of Steri-Strip™ skin closure strips according to a standardized study protocol.
  • Device: Steri-Strip™ Skin Closures
    Application of Steri-Strip adhesive skin closure strips following standard cesarean section wound closure according to a standardized protocol.
  • Procedure: Standard Cesarean Wound Closure
    Standard skin closure performed following cesarean delivery according to institutional practice.
Active Comparator
Standard Closure Alone
Participants undergo standard cesarean skin closure without application of Steri-Strip™ skin closure strips.
  • Procedure: Standard Cesarean Wound Closure
    Standard skin closure performed following cesarean delivery according to institutional practice.

Recruiting Locations

Riverside University Health System Medical Center
Moreno Valley, California 92555
Contact:
Matthew X Perera, DO, MS
8184800214
mattpereraruhs@gmail.com

More Details

Status
Recruiting
Sponsor
Riverside University Health System Medical Center

Study Contact

Matthew Perera, DO, MS
8184800214
matthew.perera@ruhealth.org